North America Biodefense Market to 2027 - Regional Analysis and Forecasts by North America Biodefense Market to 2027 - Regional Analysis and Forecasts by Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others); and Country

Limited Time Offer

The North American biodefense market is estimated to reach US$ 3,357.83 Mn by 2027 from US$ 1,569.29 Mn in 2019; it is projected to grow at a CAGR of 10.1% from 2019 to 2027. The growth of the biodefense market is primarily ascribed to the presence of favorable government initiatives and increase in the number of naturally occurring outbreaks. However, the limited reach of biodefense organizations is one of the major factors restraining the growth of the market. On the other hand, increasing adoption of technologies is expected to have a positive impact on the growth of the North American biodefense market in the coming years. 
Biodefense refers to the measures taken to restore biosecurity of a group of organisms that are subject to, or are likely to be subject to, biological threats or infectious diseases. It is an effective public health care system with strong disease surveillance and rapid actions designed to counter biological threats, to limit the spread of disease and provide medical surge.
Every year, the governments of North American countries spend heavy amounts on the R&D of vaccines to stay prepared for any bioterrorism attacks. For instance, in 2018, the US government released the National Biodefense Strategy and Implementation Plan, the National Security Strategy, the National Defense Strategy, and the National Counterterrorism Strategy, and the National Counter WMD Strategy, all of which include biosecurity and biodefense. In addition, the US government is also preparing for Global Health Security Strategy and supporting the development of a 2024 framework of the Global Health Security Agenda, which involves prevention, detection, and response to natural, accidental, and intentional biological threats.

The Executive Order 13887, “Modernizing Influenza Vaccines in the United States to Promote National Security and Public Health,” focuses on creating the National Influenza Vaccine Task Force to reform the domestic influenza vaccine enterprise in the US and also guides certain federal agencies to make specific actions toward achieving the goal. The Order provides budget of US$ 95 million that was higher than that compared to the 2020 enacted level, across Health and Human Services (HHS) for influenza vaccine manufacturing infrastructure and innovation, advanced research and development of improved vaccines, therapeutics and diagnostics, international pandemic preparedness, and improved vaccine coverage nationwide. Also, the budget covers the HHS biodefense and emergency preparedness procurement through the BioShield program and the Strategic National Stockpile. Further, it includes the budget of US$ 175 million, with a hike of US$ 50 million compared to the 2020 enacted level to support the global health security activities of the Centers For Disease Control and Prevention (CDC).
In 2004, the United States Congress passed the Project BioShield Act, calling for USD 5 billion investments for purchasing vaccines, which can be used in the event of bioterrorist attacks. This act was designed to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. Various biosecurity-related initiatives have been planned, particularly in the matured markets, such as North America. For example, in 2017, more than 50 public and private sector biosecurity stakeholders engaged in a meeting in Johns Hopkins Center, Washington DC, for making recommendations toward the National Biodefense Strategy and Implementation Plan. As the government engages in the consolidation of current and future policies, the pharmaceutical companies operating in the biodefense market have considerable opportunities to expand and be prepared for bioterrorism. For instance, Spero Therapeutics, an antibiotic developer, has received US$ 15.7 million in federal research funding from Biomedical Advanced Research and Development Authority for its oral carbapenem-class candidate, SPR994. The funding was meant to be directed toward evaluating the drug’s effectiveness against biological threats, including anthrax, plague, and melioidosis. In addition, Biomedical Advanced Research and Development Authority also includes provisions for up to an additional US$ 28.5 million over the next five years, and it would also support Spero’s clinical development of SPR994, which is effective against complicated urinary tract infections caused by drug-resistant bacteria. 
In 2019, the anthrax segment accounted for the largest market share in the North American biodefense market, based on product, that further estimated to mark the highest CAGR in the market during 2020–2027.
A few of the significant primary and secondary sources referred to while preparing this report on the biodefense market include the CDC, Food and Drug Administration (FDA), Health and Human Services (HHS), National Health Service (NHS), and Nuclear Threat Initiative (NTI).
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Biodefense Market – By Product
1.3.2 North America Biodefense Market – By Country
2. North America Biodefense Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Biodefense Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 4.2.1 Biodefense Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Biodefense Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Presence of Favourable Government Initiatives
5.1.2 Increase in the Number of Naturally Occurring Outbreaks
5.2 Key Restraints
5.2.1 Limited Reach of Biodefense Organizations
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Technologies
5.4 Future Trend
5.4.1 Predictive Analytics to Reshape Biodefense Market
5.5 Impact Analysis
6. Biodefense Market – North America Analysis
6.1 North America Biodefense Market Revenue Forecasts and Analysis
6.2 Market Positioning of Key Players
7. North America Biodefense Market Analysis and Forecasts To 2027 – By Product Type
7.1 Overview
7.2 Biodefense Market Revenue Share, by Product (2019 and 2027)
7.1 Anthrax
7.1.1 Overview
7.1.2 Anthrax: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)
7.2 Small pox
7.2.1 Overview
7.2.2 Small pox: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)
7.3 Botulism
7.3.1 Overview
7.3.2 Botulism: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Radiation/Nuclear
7.4.1 Overview
7.4.2 Radiation/Nuclear: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)
8. Biodefense Market Revenue and Forecasts To 2027 – Geographical Analysis
8.1 North America Biodefense Market Revenue and Forecasts To 2027
8.1.1 Overview
8.1.2 North America: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.3 North America: Biodefense Market, by Product, 2018–2027 (USD Million)
8.1.4 North America: Biodefense Market, by Country, 2019 & 2027 (%)
8.1.5 US: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.1 US: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.5.2 US: Biodefense Market, by Product Type, 2018–2027 (USD Million)
8.1.6 Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.1 Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.6.2 Canada: Biodefense Market, by Product Type, 2018–2027 (USD Million)
8.1.7 Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.1 Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million)
8.1.7.2 Mexico: Biodefense Market, by Product Type, 2018–2027 (USD Million)
9. North America Biodefense Market Industry Landscape
9.1 Overview
9.2 Growth Strategies in The Biodefense Market, 2016-2020
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. COMPANY PROFILES
10.1 Bavarian Nordic
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Alnylam Pharmaceuticals, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 SIGA Technologies
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Emergent BioSolutions Inc.
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Cleveland Bio Labs
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Dynavax Technologies
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Elusys Therapeutics, Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Soligenix
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Altimmune
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Pluristem
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms

LIST OF TABLES Table 1. North America Biodefense Market, by Product– Revenue and Forecast to 2027 (USD Million) Table 2. US Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million) Table 3. Canada Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million) Table 4. Mexico Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million) Table 5. Recent Inorganic Growth Strategies In The Biodefense Market Table 6. Recent Organic Growth Strategies In The Biodefense Market Table 7. Glossary of Terms, Skin aesthetic devices market LIST OF FIGURES Figure 1. Biodefense Market Segmentation Figure 2. North America Biodefense Market Overview Figure 3. Anthrax Segment Held Largest Share of Product Segment in Biodefense Market Figure 4. US Is Expected to Show Remarkable Growth During the Forecast Period Figure 5. North America Biodefense Market- Leading Country Markets (US$ Mn) Figure 6. North America Biodefense Market, Industry Landscape Figure 7. Biodefense Market - North America PEST Analysis Figure 8. Biodefense Market Impact Analysis of Drivers and Restraints Figure 9. North America Biodefense Market – Revenue Forecasts and Analysis – 2019- 2027 Figure 10. Market Positioning Of Key Players In Global Biodefense Market Figure 11. Biodefense Market Revenue Share, by Product (2019 and 2027) Figure 12. Anthrax: Biodefense Market – Revenue and Forecast to 2027 (US$ Million) Figure 13. Small pox: Biodefense Market – Revenue and Forecast to 2027 (US$ Million) Figure 14. Botulism: Biodefense Market – Revenue and Forecast to 2027 (US$ Million) Figure 15. Radiation/Nuclear: Biodefense Market – Revenue and Forecast to 2027 (US$ Million) Figure 16. Others: Biodefense Market – Revenue and Forecast to 2027 (US$ Million) Figure 17. North America: Biodefense Market, by Key Country – Revenue (2019) (USD Million) Figure 18. North America Biodefense Market Revenue and Forecast to 2027 (USD Million) Figure 19. North America: Biodefense Market, by Country, 2019 & 2027 (%) Figure 20. US: Biodefense Market – Revenue and Forecast to 2027 (USD Million) Figure 21. Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million) Figure 22. Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million) Figure 23. Growth Strategies in the Biodefense Market, 2016-2020

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Biotechnology Reports

Global Pyrogen Testing Market Size study, by Application (Pharmaceuticals and Biologicals Manufacturing, Medicals Devices Manufacturing, Other Applications) By Product (Kits and Reagents, Services, Instruments) By TEST (LAL Test, In Vitro Pyrogen Test, Rabbit Test) and Regional Forecasts 2019-2026

Global Pyrogen Testing Market is valued approximately USD 758.4 million in 2018 and is anticipated to grow with a healthy growth rate of more than 11.50% over the forecast period 2019-2026. Pyrogen testing is a procedure that defines the existence of...

Global Microscopy Market Size study, by Product (Microscopes, Software, Accessories), by Type (Optical Microscopes, Electron Microscopes, Scanning Probe Microscopes, Others), by Application (Semiconductors, Lifesciences, Material Science, Others), by End-User (Industries, Academic & Research Institutes) and Regional Forecasts 2019-2026

Global Microscopy Market is valued approximately at USD 5.92 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2019-2026. A microscopy have three well-recognized branches of microscopy t...

Global Industrial Agitator Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Industrial Agitator market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Industr...

Global Industrial UPS Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Industrial UPS market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Industrial U...

Global Industrial Brakes Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026

According to HJ Research's study, the global Industrial Brakes market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Industria...

Other Reports by The Insight Partners

Europe Push to Talk Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Component (Hardware, Software, Services); Enterprise Size (SMEs, Large Enterprises); Network Type (Land Mobile Radio, Cellular); End User (Government and Defense, Transportation and Logistics, Travel and Hospitality, Energy and Utilities, Construction, Manufacturing, Others)

Push to Talk Market to 2027- : Covid-19 Impact and Europe Analysis by Component (Hardware, Software, Services); Enterprise Size (SMEs, Large Enterprises); Network Type (Land Mobile Radio, Cellular); End-user (Government and Defense, Transportation an...

North America Photovoltaic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Application (Residential Applications, Commercial, Utility Applications); Type (Organic Components, Inorganic Components); Component (Cells, Optics, Trackers)

Photovoltaic Market to 2027 –Covid-19 Impact and North American Analysis by Type (Organic Components, Inorganic Components); Component (Cells, Optics, Trackers); Application (Residential Applications, Commercial Applications, Utility Applications);...

North America Utility communication Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility)

Utility communication Market to 2027-: Covid-19 Impact and North America Analysis by Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility); and Country The utility communication market in North America was valued at US$ 3,198.1...

Europe Utility communication Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility)

European Utility Communication Market to 2027- : By Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility); and Country The utility communication market in Europe was valued at US$ 2510.5 million in 2019 and is projected to reac...

Asia Pacific Utility communication Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility)

Utility communication Market to 2027- : Covid-19 Impact and Asia-Pacific Analysis by Technology (Wired, Wireless); Utility Type (Private Utility, Public Utility); and Country The utility communication market was valued at US$ 3,279.5 million in 2019 ...

Publisher: The Insight Partners
Chat with us